Arbor Sense
1 known investors
Arborsense develops transdermal wearable sensors that monitor biomarkers in sweat, including the SCANar wrist-worn sweat collection device, providing non-invasive alcohol and substance monitoring. Its products target compliance use cases in law enforcement, workplace safety, rehabilitation, and healthcare, as well as research into substance use, metabolic health, and disease.
Investors · 1
Non-dilutive funding · 5 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $985.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $307.1K |
| National Science Foundation | Phase II | 2017 | $145.2K |
| National Science Foundation | Phase I | 2016 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Arbor Sense do?
- Arborsense develops transdermal wearable sensors that monitor biomarkers in sweat, including the SCANar wrist-worn sweat collection device, providing non-invasive alcohol and substance monitoring. Its products target compliance use cases in law enforcement, workplace safety, rehabilitation, and healthcare, as well as research into substance use, metabolic health, and disease.
- Who are Arbor Sense's investors?
- Arbor Sense's investors include ID Ventures.